Vertigo relief app

📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.

TL;DR

Vertigo relief app

A proposed vertigo relief app is being developed to assist adults with BPPV in self-managing their condition using guided maneuvers and real-time head-angle feedback. The app targets a growing digital therapeutics market and aims to complement clinical care.

A new vertigo relief app is in development to assist adults suffering from recurrent positional vertigo or BPPV, aiming to improve self-treatment accuracy and reduce relapse rates. The app is designed for use alongside clinical care, with potential for recommendation by ENT clinics, audiologists, and vestibular physiotherapists, as part of home-based management strategies.

The proposed app will feature guided, animated step-by-step instructions for performing the Epley and Brandt-Daroff maneuvers, supplemented by audio cues and gyroscope-based head-angle feedback using smartphone sensors. It will include a screening tool to assess BPPV candidacy, a symptom and episode tracker, and recurrence coaching. The app’s core will be available for free on iOS and Android, with premium features such as detailed history export, reminders, and advanced tracking offered via subscription.

Market opportunities are driven by the increasing adoption of telehealth, the maturation of reimbursement policies for digital therapeutics, and the high prevalence of BPPV, especially among older adults and women. The digital vestibular rehab market was valued near USD 498 million in 2024, with a projected compound annual growth rate of approximately 13.5% through 2033.

Validation efforts include launching a landing page with a no-code guided maneuver demo, running targeted ads to vertigo search terms, and measuring engagement metrics such as signups and completed flows. For example, see guest app with day-of seating lookup and schedule. Additionally, outreach to 10-15 ENT and physiotherapy clinics aims to gauge clinical interest in recommending the app for between-visit home care, with feedback informing further development.

At a glance
reportWhen: ongoing development with initial testin…
The developmentDevelopment of a mobile app designed to guide patients through vertigo repositioning maneuvers and track symptoms for better self-management of BPPV.

Potential Impact on Vertigo Self-Management

This app could significantly improve the quality of self-treatment for BPPV, reducing the likelihood of incorrect maneuver performance and subsequent relapse. By integrating real-time head-position feedback and symptom tracking, it offers a more precise, accessible alternative to static diagrams and generic instructions. Its development aligns with broader trends toward telehealth and digital therapeutics, potentially easing the burden on healthcare systems and improving patient outcomes.

Amazon

Epley maneuver guide app

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Growing Need for Home-Based Vertigo Care

Benign paroxysmal positional vertigo (BPPV) is the most common vestibular disorder, often requiring repositioning maneuvers like the Epley to resolve symptoms. However, patients frequently face long wait times for specialist care and struggle to perform these maneuvers correctly at home, leading to high recurrence rates. The COVID-19 pandemic accelerated the shift toward telehealth and home rehab solutions, creating opportunities for digital tools to support self-management. The market for digital vestibular rehabilitation platforms has expanded rapidly, reflecting increased acceptance among providers and payers.

“Integrating motion sensors with guided instructions can improve maneuver accuracy and reduce relapse in BPPV patients.”

— an anonymous researcher

Amazon

vestibular rehabilitation head sensor device

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Uncertain Aspects of App Validation and Adoption

It remains unclear how effectively users will perform maneuvers with app guidance outside clinical settings, and whether clinicians will widely recommend or white-label the app for patient use. The actual effectiveness in reducing relapse rates has yet to be established through clinical trials, and user adherence over time is still uncertain.

GPS Tracker for Vehicles Works with iOS & Android App No Subscription Required, with Built-in Speaker Magnetic Car Locator 2-Year Battery Life Location History & Location Sharing

GPS Tracker for Vehicles Works with iOS & Android App No Subscription Required, with Built-in Speaker Magnetic Car Locator 2-Year Battery Life Location History & Location Sharing

【NO MONTHLY FEES OR SUBSCRIPTIONS】 Track your vehicle without recurring costs. Enjoy reliable location monitoring with a one-time…

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Next Steps in Testing and Market Engagement

The development team plans to launch a lightweight landing page and a no-code guided Epley demo to gauge initial interest. They will run targeted advertising campaigns to vertigo-related search terms, measuring signups and completion rates. Simultaneously, outreach to ENT and physiotherapy clinics will seek to validate clinical demand and explore licensing opportunities for integration into existing patient care workflows. Further development will depend on feedback from these pilots and early user testing.

Amazon

home vertigo repositioning tools

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Key Questions

How does the app guide users through vertigo maneuvers?

The app provides animated step-by-step instructions, audio cues, and real-time head-angle feedback using smartphone gyroscope sensors to ensure correct positioning during maneuvers like the Epley.

Is the app a substitute for professional medical advice?

No, the app includes a prominent disclaimer stating it is not a substitute for medical consultation and advises users to see a healthcare professional if symptoms worsen or red-flag signs appear.

Will the app be available for free?

The basic maneuver guidance will be free, with additional features such as detailed symptom tracking, history export, and reminders offered through a subscription model.

When will the app be available for general use?

The app is currently in development, with initial testing and validation planned for 2024. A wider rollout will depend on pilot results and clinical validation outcomes.

Can ENT clinics white-label the app for their patients?

Yes, there is potential for clinics to license or white-label the app as part of their patient home-care programs, pending validation and market interest.

Source: IdeaNavigator AI

You May Also Like

Genetic Medicine 2025: Are CRISPR Cures Becoming Reality?

Medical breakthroughs with CRISPR in 2025 are revolutionizing treatment options, but ethical and safety questions leave us wondering what’s next.

Lab-Grown Organs: Are We Closer to Solving the Transplant Crisis in 2025?

Absolutely, lab-grown organs could revolutionize transplants by 2025, but critical ethical and policy challenges remain to be addressed.

The Truth About Low-EMF Claims in Home Saunas

Low-EMF claims in home saunas can be misleading because infrared radiation, which…

Cancer Moonshot 2025: Progress in the Quest to End Cancer

Keen progress in Cancer Moonshot 2025 is transforming cancer treatment—discover how innovative therapies are bringing us closer to ending cancer.